Hamaguchi Masahide, Kojima Takao, Itoh Yoshito, Harano Yuichi, Fujii Kota, Nakajima Tomoaki, Kato Takahiro, Takeda Noriyuki, Okuda Junichi, Ida Kazunori, Kawahito Yutaka, Yoshikawa Toshikazu, Okanoue Takeshi
Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Am J Gastroenterol. 2007 Dec;102(12):2708-15. doi: 10.1111/j.1572-0241.2007.01526.x. Epub 2007 Sep 25.
Nonalcoholic fatty liver disease (NAFLD) is closely associated with the metabolic syndrome.
We evaluated the association among the metabolic syndrome, visceral fat accumulation, and the severity of fatty liver with a new scoring system of ultrasonographic findings in apparently healthy Japanese adults.
Subjects consisted of 94 patients who received liver biopsy and 4,826 participants who were selected from the general population. Two hepatologists scored the ultrasonographic findings from 0 to 6 points. We calculated Cohen's kappa of within-observer reliability and between-observer reliability. We evaluated the predictive value of the score by the area under a conventional receiver operating characteristic curve (AUC).
Within-observer reliability was 0.95 (95% CI 0.93-0.97, P<0.001) and between-observer reliability was 0.95 (95% CI 0.93-0.97, P<0.001). The AUC to diagnose NAFLD was 0.980. The sensitivity was 91.7% (95% CI 87.0-95.1, P<0.001) and the specificity was 100% (95% CI 95.4-100.0, P<0.001). The AUC to diagnose visceral obesity was 0.821. The sensitivity was 68.3% (95% CI 51.9-81.9, P=0.028) and the specificity was 95.1% (95% CI 86.3-99.0, P<0.001). Adjusted odds ratio of the score for the metabolic syndrome was 1.37 (95% CI 1.26-1.49, P<0.001).
The scoring system with abdominal ultrasonography could provide accurate information about hepatic steatosis, visceral obesity, and the metabolic syndrome in apparently healthy people who do not consume alcohol.
非酒精性脂肪性肝病(NAFLD)与代谢综合征密切相关。
我们使用一种新的超声检查结果评分系统,评估了代谢综合征、内脏脂肪堆积和脂肪肝严重程度在表面健康的日本成年人中的关联。
研究对象包括94例接受肝活检的患者和从普通人群中选取的4826名参与者。两名肝病专家对超声检查结果从0至6分进行评分。我们计算了观察者内信度和观察者间信度的Cohen's kappa值。我们通过传统受试者工作特征曲线(AUC)下的面积评估该评分的预测价值。
观察者内信度为0.95(95%CI 0.93 - 0.97,P<0.001),观察者间信度为0.95(95%CI 0.93 - 0.97,P<0.001)。诊断NAFLD的AUC为0.980。敏感性为91.7%(95%CI 87.0 - 95.1,P<0.001),特异性为100%(95%CI 95.4 - 100.0,P<0.001)。诊断内脏肥胖的AUC为0.821。敏感性为68.3%(95%CI 51.9 - 81.9,P = 0.028),特异性为95.1%(95%CI 86.3 - 99.0,P<0.001)。代谢综合征评分的校正比值比为1.37(95%CI 1.26 - 1.49,P<0.001)。
腹部超声评分系统可为不饮酒的表面健康人群提供有关肝脂肪变性、内脏肥胖和代谢综合征的准确信息。